Product Images Pirfenidone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Pirfenidone NDC 69539-119 by Msn Laboratories Private Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
267-cntnr - pirfenidone 267mg 30s container label
This text is describing a medication called "Pirfenidone Tablets", which is only available with a prescription and has a National Drug Code of 69539.119.30. The tablets contain 267mg of the medication and should be stored between 15-30°C. The manufacturer is listed as "MSN Laboratories Private Limited" located in Teangana, India. The text also provides information on where to find dosage instructions.*
267-crtn - pirfenidone 267mg carton container label
Pirfenidone Tablets are available in three bottles containing 30 tablets each with an NDC code of 69538-119-71. The recommended dosage is mentioned on page 26. Store tablets at 25°C, with excursions permitted from 15°C to 30°C, and protect from light and moisture. Each tablet contains 267 mg of Pirfenidone. No other information is available.*
801-cntnr - pirfenidone 801mg 30s container label
This is a medication called "Pirfenidone Tablets" that is available only by prescription (Rx only). Each coated tablet contains 801 mg of Prenidone. The recommended dosage and administration instructions can be found in the package insert. The medication should be stored at room temperature, between 15°C-30°C (59°F-86°F). The tablets are manufactured by MSN Laboratories Private Limited in Telangana, India and distributed by MSN Pharmaceuticals Inc. The product comes in a bottle containing 30 tablets and should be kept out of reach of children.*
801-crtn - pirfenidone 801mg carton container label
fig1 - pirfenidone figure 1
fig2 - pirfenidone figure 2
fig3 - pirfenidone figure 3
This is a survival analysis table showing the percentage of patients alive who were treated with Pirfenidone (n=623) compared to the placebo (n=624) over a period of weeks. The HR (hazard ratio) with a 95% confidence interval was 0.75 (0.51-1.11). The table also shows the number of patients at risk at different points in time.*
str - pirfenidone str
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.